4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000899243-23-006786
Chief Executive Officer sold 8,273 shares at $3.51 ($29,038)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2023-03-01 | Sale | −8,273 | $3.51 | $29,038 | 238,959 | D |
| Open-market sales · 8,273 sh · avg $3.51 · $29,038 | |||||||
Loading xslF345X03/doc4.xml…